Cargando…

Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases

[Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayfer, Tatyana D., Yamani, Khalil, Jung, Erik, Chesnokov, Gleb A., Ferrara, Isabella, Hsiao, Chien-Chi, Georgiou, Antri, Michel, Jeremy, Bailly, Aurélien, Sieber, Simon, Eberl, Leo, Gademann, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131216/
https://www.ncbi.nlm.nih.gov/pubmed/37124289
http://dx.doi.org/10.1021/jacsau.3c00037
_version_ 1785031128979079168
author Grayfer, Tatyana D.
Yamani, Khalil
Jung, Erik
Chesnokov, Gleb A.
Ferrara, Isabella
Hsiao, Chien-Chi
Georgiou, Antri
Michel, Jeremy
Bailly, Aurélien
Sieber, Simon
Eberl, Leo
Gademann, Karl
author_facet Grayfer, Tatyana D.
Yamani, Khalil
Jung, Erik
Chesnokov, Gleb A.
Ferrara, Isabella
Hsiao, Chien-Chi
Georgiou, Antri
Michel, Jeremy
Bailly, Aurélien
Sieber, Simon
Eberl, Leo
Gademann, Karl
author_sort Grayfer, Tatyana D.
collection PubMed
description [Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group in the 4-position (carbohydrate numbering). To test this hypothesis, carbocyclic inhibitors with leaving groups in the 4- and 6- positions were prepared. The results of enzyme kinetics analyses demonstrated that dinitrophenyl ethers covalently inhibit α-glucosidases of the GH13 family without reactivation. The labeled enzyme was studied by proteomics, and the active site residue Asp214 was identified as modified. Additionally, computational studies, including enzyme homology modeling and density functional theory (DFT) calculations, further delineate the electronic and structural requirements for activity. This study demonstrates that previously unexplored 4- and 6-positions can be exploited for successful inhibitor design.
format Online
Article
Text
id pubmed-10131216
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101312162023-04-27 Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases Grayfer, Tatyana D. Yamani, Khalil Jung, Erik Chesnokov, Gleb A. Ferrara, Isabella Hsiao, Chien-Chi Georgiou, Antri Michel, Jeremy Bailly, Aurélien Sieber, Simon Eberl, Leo Gademann, Karl JACS Au [Image: see text] Allylic cyclitols were investigated as covalent inhibitors of glycoside hydrolases by chemical, enzymatic, proteomic, and computational methods. This approach was inspired by the C(7) cyclitol natural product streptol glucoside, which features a potential carbohydrate leaving group in the 4-position (carbohydrate numbering). To test this hypothesis, carbocyclic inhibitors with leaving groups in the 4- and 6- positions were prepared. The results of enzyme kinetics analyses demonstrated that dinitrophenyl ethers covalently inhibit α-glucosidases of the GH13 family without reactivation. The labeled enzyme was studied by proteomics, and the active site residue Asp214 was identified as modified. Additionally, computational studies, including enzyme homology modeling and density functional theory (DFT) calculations, further delineate the electronic and structural requirements for activity. This study demonstrates that previously unexplored 4- and 6-positions can be exploited for successful inhibitor design. American Chemical Society 2023-03-20 /pmc/articles/PMC10131216/ /pubmed/37124289 http://dx.doi.org/10.1021/jacsau.3c00037 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Grayfer, Tatyana D.
Yamani, Khalil
Jung, Erik
Chesnokov, Gleb A.
Ferrara, Isabella
Hsiao, Chien-Chi
Georgiou, Antri
Michel, Jeremy
Bailly, Aurélien
Sieber, Simon
Eberl, Leo
Gademann, Karl
Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title_full Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title_fullStr Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title_full_unstemmed Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title_short Allylic Carbocyclic Inhibitors Covalently Bind Glycoside Hydrolases
title_sort allylic carbocyclic inhibitors covalently bind glycoside hydrolases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131216/
https://www.ncbi.nlm.nih.gov/pubmed/37124289
http://dx.doi.org/10.1021/jacsau.3c00037
work_keys_str_mv AT grayfertatyanad allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT yamanikhalil allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT jungerik allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT chesnokovgleba allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT ferraraisabella allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT hsiaochienchi allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT georgiouantri allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT micheljeremy allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT baillyaurelien allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT siebersimon allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT eberlleo allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases
AT gademannkarl allyliccarbocyclicinhibitorscovalentlybindglycosidehydrolases